Found: 34
Select item for more details and to access through your institution.
Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin–bilirubin grade.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 4, p. 739, doi. 10.1007/s10147-022-02117-9
- By:
- Publication type:
- Article
Easy albumin–bilirubin score as a new prognostic predictor in hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2021, v. 51, n. 11, p. 1129, doi. 10.1111/hepr.13671
- By:
- Publication type:
- Article
Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 1925, doi. 10.3390/cancers15071925
- By:
- Publication type:
- Article
Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 753, doi. 10.3390/cancers15030753
- By:
- Publication type:
- Article
Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4207, doi. 10.3390/cancers14174207
- By:
- Publication type:
- Article
Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1130, doi. 10.3390/cancers12051130
- By:
- Publication type:
- Article
Predicting post‐resection early recurrence of hepatocellular carcinoma: Defining the role of microvascular invasion.
- Published in:
- Liver International, 2023, v. 43, n. 12, p. 2826, doi. 10.1111/liv.15743
- By:
- Publication type:
- Article
Look for new biomarkers in the management of hepatocellular carcinoma: What the hepatologists may need to know.
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 260, doi. 10.1111/liv.15483
- By:
- Publication type:
- Article
Changing epidemiological features of hepatocellular carcinoma: Taiwan's position.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2911, doi. 10.1111/liv.15442
- By:
- Publication type:
- Article
3‐Mercaptopyruvate sulfurtransferase in hepatocellular carcinoma: Is it an authentic clinical prognostic predictor?
- Published in:
- Liver International, 2022, v. 42, n. 6, p. 1475, doi. 10.1111/liv.15279
- By:
- Publication type:
- Article
Improving the accuracy of outcome prediction for hepatocellular carcinoma: Asia strategies.
- Published in:
- Liver International, 2022, v. 42, n. 3, p. 714, doi. 10.1111/liv.15167
- By:
- Publication type:
- Article
Nomogram for surgical hepatocellular carcinoma: What have we missed?
- Published in:
- Liver International, 2021, v. 41, n. 12, p. 3034, doi. 10.1111/liv.15071
- By:
- Publication type:
- Article
Changing faces of hepatocellular carcinoma: East vs West.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1430, doi. 10.1111/liv.14753
- By:
- Publication type:
- Article
Post hepatitis B‐eliminated hepatocellular carcinoma: New challenges.
- Published in:
- Liver International, 2021, v. 41, n. 5, p. 1173, doi. 10.1111/liv.14878
- By:
- Publication type:
- Article
Predicting microvascular invasion in HCC with ctDNA: What are the pitfalls?
- Published in:
- Liver International, 2021, v. 41, n. 5, p. 1148, doi. 10.1111/liv.14536
- By:
- Publication type:
- Article
Are inflammation‐based models feasible tools in predicting the outcome of patients with hepatocellular carcinoma?
- Published in:
- Liver International, 2020, v. 40, n. 6, p. 1498, doi. 10.1111/liv.14341
- By:
- Publication type:
- Article
Albumin‐bilirubin grade‐based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma.
- Published in:
- Liver International, 2020, v. 40, n. 1, p. 205, doi. 10.1111/liv.14249
- By:
- Publication type:
- Article
Metastasis in patients with hepatocellular carcinoma: Prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer system.
- Published in:
- Liver International, 2018, v. 38, n. 10, p. 1803, doi. 10.1111/liv.13748
- By:
- Publication type:
- Article
Microvascular Invasion as a Prognostic Predictor in Hepatocellular Carcinoma: How Accurate Is It?
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-61028-9
- By:
- Publication type:
- Article
Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 11, p. 3196, doi. 10.1111/jgh.15593
- By:
- Publication type:
- Article
Treating Small Hepatocellular Carcinoma: Stereotactic Body Radiation Therapy Versus Radiofrequency Ablation.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 11, p. 2020, doi. 10.1111/jgh.15126
- By:
- Publication type:
- Article
Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging Determinants.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Changing patterns of etiology and management of hepatocellular carcinoma: need for global reappraisal.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Evolution of hepatocellular carcinoma: non-B, non-C and beyond.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-33536-2
- By:
- Publication type:
- Article
Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal Insufficiency.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16987, doi. 10.3390/ijms242316987
- By:
- Publication type:
- Article
Surgical resection versus transarterial chemoembolization for patients with hepatocellular carcinoma beyond Milan criteria: prognostic role of tumor burden score.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41068-7
- By:
- Publication type:
- Article
Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0188031
- By:
- Publication type:
- Article
Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0180408
- By:
- Publication type:
- Article
Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0174333
- By:
- Publication type:
- Article